Concepedia

Publication | Open Access

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster

DOIFull Paper Access

15

Citations

30

References

2023

Year

Terry Nolan, Georgia Deliyannis, Maryanne Griffith, Sabine Braat, Lilith F. Allen, Jennifer Audsley, Amy W. Chung, Marcin Ciula, Nicholas A. Gherardin, Michelle Giles,
EBioMedicine

Abstract

Australian Government Medical Research Future Fund, and philanthropies Jack Ma Foundation and IFM investors.

References

YearCitations

Page 1